211678-96-5 Usage
General Description
3-Chloroisonicotinic acid ethyl ester is a chemical compound with the chemical formula C8H8ClNO2. It is the ethyl ester of 3-chloroisonicotinic acid, and it is often used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. 3-CHLOROISONICOTINIC ACID ETHYL ESTER is a pale yellow liquid with a strong odor, and it is soluble in organic solvents such as ethanol and acetone. It is primarily used as a building block for the synthesis of other organic compounds, and it is known to have a wide range of applications in the pharmaceutical and agricultural industries. It is important to handle this compound with care, as it can be hazardous if not properly managed.
Check Digit Verification of cas no
The CAS Registry Mumber 211678-96-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,1,6,7 and 8 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 211678-96:
(8*2)+(7*1)+(6*1)+(5*6)+(4*7)+(3*8)+(2*9)+(1*6)=135
135 % 10 = 5
So 211678-96-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H8ClNO2/c1-2-12-8(11)6-3-4-10-5-7(6)9/h3-5H,2H2,1H3
211678-96-5Relevant articles and documents
NEW ANTHELMINTIC COMPOUNDS
-
Page/Page column 86; 99-100, (2020/05/28)
The present invention relates to novel compounds of general formula (I) with A being A1 or A2, and in which T, X, Y, Ro, R1, R10 and R11 are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.
HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS
-
Page/Page column 69, (2013/03/26)
The invention relates to heterocyclic amide derivatives of formula (I), wherein R1, R2, R3, R4, R5, X, Y and n are as defined in the description, their preparation and their use as pharmaceutically active compounds.
